KalVista Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
KalVista Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending July 31, 2024 was 43.1M shares, a 25.7% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 43.1M +8.82M +25.7% Jul 31, 2024 10-Q 2024-09-05
Q1 2024 42.5M +8.35M +24.4% Apr 30, 2024 10-Q 2024-09-05
Q4 2023 34.6M +468K +1.37% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 34.4M +9.82M +39.9% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 34.3M +9.7M +39.5% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 34.2M +9.62M +39.2% Apr 30, 2023 10-K 2024-07-11
Q4 2022 34.1M +9.59M +39.1% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 24.6M +159K +0.65% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 24.6M +133K +0.55% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 24.6M +128K +0.53% Apr 30, 2022 10-K 2023-07-10
Q4 2021 24.5M +6.52M +36.2% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 24.4M +6.53M +36.4% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 24.4M +6.56M +36.7% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 24.4M +6.58M +36.9% Apr 30, 2021 10-K 2022-07-07
Q4 2020 18M +176K +0.98% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 17.9M +81.4K +0.46% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 17.9M +64.9K +0.36% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 17.8M +568K +3.29% Apr 30, 2020 10-K 2021-07-13
Q4 2019 17.8M +598K +3.47% Jan 31, 2020 10-Q 2020-03-10
Q3 2019 17.8M +609K +3.54% Oct 31, 2019 10-Q 2019-12-03
Q2 2019 17.8M +7.02M +65% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 17.3M +6.48M +60% Apr 30, 2019 10-K 2020-07-01
Q4 2018 17.2M +6.45M +59.8% Jan 31, 2019 10-Q 2019-03-14
Q3 2018 17.2M +6.44M +59.7% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 10.8M +1.09M +11.2% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 10.8M +1.09M +11.2% Apr 30, 2018 10-K 2019-07-16
Q4 2017 10.8M +1.08M +11.1% Jan 31, 2018 10-Q 2018-03-16
Q3 2017 10.8M -15.6M -59.1% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 9.71M -16.6M -63.1% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 9.71M -16.6M -63.1% Apr 30, 2017 10-K 2018-07-30
Q4 2016 9.71M -16.6M -63.1% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 26.3M +21.6K +0.08% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 26.3M +13.3K +0.05% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 26.3M +25.6M +3617% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 26.3M +25.6M +3708% Dec 31, 2015 10-Q 2016-11-08
Q3 2015 26.3M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 26.3M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 708K Mar 31, 2015 10-Q 2015-05-21
Q4 2014 691K Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.